We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CPHI market cap is 3.95M. The company's latest EPS is USD -0.1599 and P/E is -1.31.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.83M | 2.14M | 1.37M | 925k | 1.1M |
| Operating Income | -708k | -1.18M | -916k | -1.39M | -1.09M |
| Net Income | -778k | -1.23M | -956k | -1.44M | -1.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.92M | 10.87M | 9.9M | 8.2M | 7.03M |
| Operating Income | -20.41M | -2.58M | -2.86M | -3.55M | -2.75M |
| Net Income | -20.7M | -2.87M | -3.4M | -3.97M | -3.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.35M | 16.47M | 16.19M | 14.26M | 13.47M |
| Total Liabilities | 9.24M | 9.01M | 7.9M | 6.85M | 6.94M |
| Total Equity | 6.11M | 7.46M | 8.29M | 7.41M | 6.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.24M | 21.12M | 22.65M | 17.78M | 16.47M |
| Total Liabilities | 13M | 13.11M | 16.63M | 13.49M | 9.01M |
| Total Equity | 9.24M | 8.01M | 6.02M | 4.29M | 7.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -677k | -700k | -586k | -658k | -705k |
| Investing | -7k | -12k | N/A | -28k | -19k |
| Financing | 43k | 74k | 7k | 14k | 21k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 608k | -42k | -250k | -410k | -700k |
| Investing | -136k | -867k | -438k | -402k | -12k |
| Financing | -1.73M | 624k | 4.6M | -1.77M | 74k |
| Market Cap | 3.95M |
| Price to Earnings Ratio | -1.31 |
| Price to Sales Ratio | 0.58 |
| Price to Cash Ratio | 2.84 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 19.25M |
| Average Volume (1 week) | 871.53k |
| Average Volume (1 Month) | 2.07M |
| 52 Week Change | -59.00% |
| 52 Week High | 0.599 |
| 52 Week Low | 0.13 |
| Spread (Intraday) | 0.02 (6.82%) |
| Company Name | China Pharma Holdings Inc |
| Address |
321 w winnie ln carson city, nevada 89703 |
| Website | https://www.chinapharmaholdings.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
